USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 175 filers reported holding USANA HEALTH SCIENCES INC in Q1 2023. The put-call ratio across all filers is 8.31 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,636 | -13.8% | 881 | -7.3% | 0.00% | – |
| Q2 2023 | $59,887 | +14.4% | 950 | +14.2% | 0.00% | – |
| Q1 2023 | $52,333 | +50.6% | 832 | +27.4% | 0.00% | – |
| Q4 2022 | $34,741 | +12.1% | 653 | +16.6% | 0.00% | – |
| Q3 2022 | $31,000 | -55.1% | 560 | -40.8% | 0.00% | – |
| Q2 2022 | $69,000 | 0.0% | 946 | +7.1% | 0.00% | – |
| Q1 2022 | $69,000 | -16.9% | 883 | +7.4% | 0.00% | – |
| Q4 2021 | $83,000 | +7.8% | 822 | -1.1% | 0.00% | – |
| Q3 2021 | $77,000 | -9.4% | 831 | -1.2% | 0.00% | – |
| Q2 2021 | $85,000 | -18.3% | 841 | -21.2% | 0.00% | – |
| Q1 2021 | $104,000 | +30.0% | 1,067 | +2.9% | 0.00% | – |
| Q4 2020 | $80,000 | -2.4% | 1,037 | -8.4% | 0.00% | – |
| Q3 2020 | $82,000 | -15.5% | 1,132 | -14.0% | 0.00% | – |
| Q2 2020 | $97,000 | +12.8% | 1,316 | -10.7% | 0.00% | – |
| Q1 2020 | $86,000 | -39.4% | 1,473 | -18.8% | 0.00% | – |
| Q4 2019 | $142,000 | +9.2% | 1,813 | -4.6% | 0.00% | – |
| Q3 2019 | $130,000 | +27.5% | 1,901 | +49.2% | 0.00% | – |
| Q2 2019 | $102,000 | -5.6% | 1,274 | 0.0% | 0.00% | – |
| Q1 2019 | $108,000 | -55.9% | 1,274 | -38.6% | 0.00% | – |
| Q4 2018 | $245,000 | -2.4% | 2,074 | -0.3% | 0.00% | – |
| Q3 2018 | $251,000 | +4.1% | 2,080 | 0.0% | 0.00% | – |
| Q2 2018 | $241,000 | +34.6% | 2,080 | +0.3% | 0.00% | – |
| Q1 2018 | $179,000 | -20.4% | 2,074 | -32.0% | 0.00% | – |
| Q4 2017 | $225,000 | +27.8% | 3,049 | +0.6% | 0.00% | – |
| Q3 2017 | $176,000 | -9.7% | 3,030 | 0.0% | 0.00% | – |
| Q2 2017 | $195,000 | -6.2% | 3,030 | -15.8% | 0.00% | – |
| Q1 2017 | $208,000 | -5.5% | 3,600 | 0.0% | 0.00% | – |
| Q4 2016 | $220,000 | -11.6% | 3,600 | +100.0% | 0.00% | – |
| Q3 2016 | $249,000 | +22.1% | 1,800 | -2.0% | 0.00% | – |
| Q2 2016 | $204,000 | -54.5% | 1,837 | -50.2% | 0.00% | -100.0% |
| Q1 2016 | $448,000 | -13.2% | 3,688 | -8.6% | 0.00% | 0.0% |
| Q4 2015 | $516,000 | -4.4% | 4,037 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $540,000 | -2.2% | 4,037 | +0.0% | 0.00% | 0.0% |
| Q2 2015 | $552,000 | +4.2% | 4,036 | -15.4% | 0.00% | 0.0% |
| Q1 2015 | $530,000 | +8.4% | 4,770 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $489,000 | +36.6% | 4,770 | -2.0% | 0.00% | – |
| Q3 2014 | $358,000 | -6.3% | 4,866 | 0.0% | 0.00% | – |
| Q2 2014 | $382,000 | -0.5% | 4,866 | -3.9% | 0.00% | -100.0% |
| Q1 2014 | $384,000 | -3.5% | 5,066 | -3.4% | 0.00% | 0.0% |
| Q4 2013 | $398,000 | -15.7% | 5,246 | -3.4% | 0.00% | 0.0% |
| Q3 2013 | $472,000 | +29.7% | 5,431 | +7.6% | 0.00% | 0.0% |
| Q2 2013 | $364,000 | – | 5,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |